Clinical Trial

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 11, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-23; most recent amendment 2025-07-08.
Trial Details
NCT Number NCT06953180
Lead Sponsor Asfendiyarov Kazakh National Medical University
Conditions Cardiovascular Diseases (CVD), Type 2 Diabetes, Chronic Respiratory Diseases, Obesity (Disorder), Chronic Kidney Diseases
Enrollment 6,720 participants
Start Date 2025-03-03
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-11